ZD-1838

N/A

Report date: 2026/05/13 20:02:10

NME

Base Information

Drug NameZD-1838

Drug Alias NameEGFR tyrokine kinase inhibitor (Zeneca)ZD-1838

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors

TargetsEpidermal growth factor receptor erbB1

Therapy Area/IndicationsLung NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesZeneca Group Plc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesZeneca Group Plc

Active IndicationsN/A

Inactive IndicationsLung NeoplasmsBreast Neoplasms

ATC CodeN/A